| Product Code: ETC6736640 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China aromatase inhibitors import market saw significant growth in 2024, with top exporting countries including India, Japan, China, Mexico, and Italy. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained high in 2024 following a very high concentration in 2023. The compound annual growth rate (CAGR) from 2020 to 2024 was 1.49%, indicating steady expansion. Notably, the growth rate from 2023 to 2024 surged to an impressive 85.8%, reflecting a strong uptrend in demand for aromatase inhibitors in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Aromatase Inhibitors Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Aromatase Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 China Aromatase Inhibitors Market - Industry Life Cycle |
3.4 China Aromatase Inhibitors Market - Porter's Five Forces |
3.5 China Aromatase Inhibitors Market Revenues & Volume Share, By Drug, 2022 & 2032F |
3.6 China Aromatase Inhibitors Market Revenues & Volume Share, By Mode of Action, 2022 & 2032F |
3.7 China Aromatase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 China Aromatase Inhibitors Market Revenues & Volume Share, By End Users, 2022 & 2032F |
3.9 China Aromatase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 China Aromatase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of breast cancer in China |
4.2.2 Growing awareness about the benefits of aromatase inhibitors in breast cancer treatment |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost associated with aromatase inhibitors |
4.3.3 Competition from alternative treatments for breast cancer |
5 China Aromatase Inhibitors Market Trends |
6 China Aromatase Inhibitors Market, By Types |
6.1 China Aromatase Inhibitors Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 China Aromatase Inhibitors Market Revenues & Volume, By Drug, 2022 - 2032F |
6.1.3 China Aromatase Inhibitors Market Revenues & Volume, By Formestane, 2022 - 2032F |
6.1.4 China Aromatase Inhibitors Market Revenues & Volume, By Fadrozole, 2022 - 2032F |
6.1.5 China Aromatase Inhibitors Market Revenues & Volume, By Exemestane, 2022 - 2032F |
6.1.6 China Aromatase Inhibitors Market Revenues & Volume, By Anastrozole, 2022 - 2032F |
6.1.7 China Aromatase Inhibitors Market Revenues & Volume, By Letrozole, 2022 - 2032F |
6.1.8 China Aromatase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 China Aromatase Inhibitors Market, By Mode of Action |
6.2.1 Overview and Analysis |
6.2.2 China Aromatase Inhibitors Market Revenues & Volume, By Selective Inhibitors, 2022 - 2032F |
6.2.3 China Aromatase Inhibitors Market Revenues & Volume, By Non-Selective Inhibitors, 2022 - 2032F |
6.3 China Aromatase Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Aromatase Inhibitors Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.3 China Aromatase Inhibitors Market Revenues & Volume, By Parenteral, 2022 - 2032F |
6.4 China Aromatase Inhibitors Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 China Aromatase Inhibitors Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 China Aromatase Inhibitors Market Revenues & Volume, By Homecare, 2022 - 2032F |
6.4.4 China Aromatase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 China Aromatase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 China Aromatase Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Aromatase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.5.3 China Aromatase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
6.5.4 China Aromatase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.5.5 China Aromatase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
7 China Aromatase Inhibitors Market Import-Export Trade Statistics |
7.1 China Aromatase Inhibitors Market Export to Major Countries |
7.2 China Aromatase Inhibitors Market Imports from Major Countries |
8 China Aromatase Inhibitors Market Key Performance Indicators |
8.1 Number of new breast cancer cases diagnosed annually in China |
8.2 Adoption rate of aromatase inhibitors in breast cancer treatment |
8.3 Number of healthcare facilities offering aromatase inhibitors therapy |
8.4 Research and development investment in aromatase inhibitors in China |
8.5 Patient adherence and compliance rates to aromatase inhibitors therapy |
9 China Aromatase Inhibitors Market - Opportunity Assessment |
9.1 China Aromatase Inhibitors Market Opportunity Assessment, By Drug, 2022 & 2032F |
9.2 China Aromatase Inhibitors Market Opportunity Assessment, By Mode of Action, 2022 & 2032F |
9.3 China Aromatase Inhibitors Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 China Aromatase Inhibitors Market Opportunity Assessment, By End Users, 2022 & 2032F |
9.5 China Aromatase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 China Aromatase Inhibitors Market - Competitive Landscape |
10.1 China Aromatase Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 China Aromatase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here